Bank of America’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Bank of America’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-80,000	Closed	-$1.58M	–	7463
2019 Q4	$1.58M	Buy	+80,000	New	+$1.28M	﹤0.01%	4192
2014 Q1	–	Sell	-78,000	Closed	-$1.38M	–	8236
2013 Q4	$1.38M	Hold	78,000	–	–	﹤0.01%	3712
2013 Q3	$1.12M	Hold	78,000	–	–	﹤0.01%	3837
2013 Q2	$1.18M	Buy	+78,000	New	+$1.03M	﹤0.01%	3847

Bank of America's MNTA Position: Q4 2020 in Review

Bank of America sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 912,332 shares — an estimated $47.9M sold.

Bank of America first reported a position in MNTA in Q2 2013 and held it in 30 quarters. The position peaked at $47.9M in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

Bank of America reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
Bank of America sold 912,332 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $47.9M.
Bank of America first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2013 and held it in 30 quarters.
Bank of America's Momenta Pharmaceuticals, Inc. position peaked at $47.9M in Q3 2020.
0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on Bank of America's 13F filing for Q4 2020, filed 10 Feb 2021.